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Incidental renal artery stenosis in peripheral vascular disease:
A case for treatment?
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Incidental renal artery stenosis in peripheral vascular disease: reported clinically in 15% of patients undergoing routine
A case for treatment? cardiac catheterization [3].
Background. Renal artery stenosis (RAS) is frequently en- There are arguments that favor treatment. Atheroscle-
countered as an incidental finding in peripheral vascular dis-
rotic RAS is a recognized cause of ischemic nephropathyease. We assessed whether revascularization is indicated to
[4, 5] and has been shown to progress over time [6–8],prevent the practical consequences of end-stage renal failure,
that is, the need for renal replacement therapy. with a reported progression rate of the stenotic lesion
Methods. In a retrospective study, a cohort of consecutive of 7% per year [6]. RAS, associated with hypertension,
patients was followed who had undergone angiography 8 to may result in chronic parenchymal ischemia and irrevers-
10 years previously for peripheral artery disease. Patients with
ible loss of renal function [9]; this has been implied asuntreated incidental RAS of $50% diameter stenosis (68.8 6
the cause of end-stage renal failure in 14% of patients9.8 years, mean 6 SD) were compared with regard to the
prevalence of renal replacement therapy to controls without .50 years of age [4]. A major rationale for revasculariz-
RAS who were matched for age and gender. ing incidentally found that RAS therefore seems to be
Results. RAS was present in 126 of 386 evaluable patients the prevention of end-stage renal failure [10]. However,
(33%). None of these patients required renal replacement ther-
there are also arguments not to treat: Why expose theseapy during the 10-year follow-up. Serum creatinine values re-
patients to the potential complications, inconvenience,mained stable during follow-up.
and costs of revascularization treatment when there is noConclusions. Incidental RAS is frequently seen in patients
with peripheral vascular disease. If left untreated, incidental immediate need to do so? The true clinical significance of
RAS seems not to result in end-stage renal failure or in a need incidentally found RAS remains unclear.
for renal replacement therapy. Revascularization with the aim To decide whether there is a case for treatment, objec-to prevent end-stage renal failure seems less indicated, and
tive data on the natural history of untreated incidentalfurther prospective studies are indicated to elucidate this issue.
RAS are needed; however, few such data are available.
Therefore, we assessed whether patients with untreated
incidentally found RAS came to the practical conse-Should incidentally found atherosclerotic renal artery
quences of end-stage renal failure (that is, need for renalstenosis (RAS) be treated? This question frequently
replacement therapy) during 10 years of follow-up, inarises whenever RAS is unexpectedly encountered dur-
comparison to matched patients without RAS.ing examinations made for other purposes, for example,
during preoperative angiography performed for periph-
eral artery disease. Renal vascular disease is a highly METHODS
underdiagnosed condition. Previous autopsy studies re- We studied a cohort of consecutive patients who under-
ported a prevalence of RAS between 30 and 56% in went digital subtraction angiography because of chronic
patients with hypertension and evidence of cardiovascu- ischemic peripheral artery disease from January 1989 to
lar disease elsewhere [1, 2]. Besides, significant RAS was December 1991. In our hospital, angiograms made for
peripheral artery disease include views of the abdominal
aorta and the renal arteries. Patients in whom the angio-Key words: atherosclerosis, end-stage renal failure, renal replacement
gram did not allow proper assessment of the renal arter-therapy, peripheral vascular disease, revascularization, hypertension,
cardiovascular disease. ies were excluded from the analysis. Also excluded were
patients who were under control of the hypertensionReceived for publication June 26, 2000
department for symptomatic RAS at the time of theand in revised form September 19, 2000
Accepted for publication October 11, 2000 angiographic examination. The study was approved by
the local ethical review board.Ó 2001 by the International Society of Nephrology
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Table 1. Distribution of severity of renal artery stenosis (RAS)The angiograms were read by two independent ob-
servers blinded to the clinical information. The presence RAS N
and severity of RAS was expressed in 10% incremental 50% 37
60% 25steps starting at RAS of $50% lumen diameter stenosis.
70% 14Differences between the two observers were solved by
80% 22
consensus. Accessory renal arteries with a stenosis were 90% 17
99% 11considered significant whenever more than one third of
the renal mass was estimated to be supplied by the vessel.
We then grouped the patients with significant RAS for
comparison with the patients without RAS as controls. It
soon became clear that patients with RAS had a different in their entirety for possible RAS in 397 of these 593
distribution of age and sex than patients without RAS angiograms. The reasons for incomplete visualization of
(Results section). Because both these parameters might the renal arteries in the 196 remaining angiograms were
affect the outcome parameter in this study, we formed technical. The renal arteries were either not visualized
the control group by obtaining a random selection of because of a relative low catheter position below the
patients without RAS who were matched for age and origin of the renal arteries or the renal arteries could
gender. not be interpreted because the available hard-copy x-ray
films [which are by necessity selected time frames from
Baseline characteristics the full digital subtraction angiographic (DSA) runs] did
Six clinical variables were recorded at baseline (that is, not show the renal arteries at optimal opacification.
the time of angiography): the Cockroft serum creatinine Some angiograms were excluded because there was inad-
clearance as a measure of renal function, a history of equate visualization of the renal artery origins because of
coronary artery disease (myocardial infarction or angina), overlap with the aorta on the used angiographic imaging
a history of cerebrovascular disease (stroke or transient projections. Of the 397 evaluable patients, 11 were ex-
ischemic attack), diabetes mellitus (present or absent), cluded because they were under control for symptomatic
smoking history (ever or never), and obesity (present or RAS at the time of the angiographic examination. The
absent; defined as a body mass index $25 kg/m2). remaining 386 eligible patients were included in the anal-
ysis. RAS was present in 126 out of 386 patients (33%),Follow-up
which was unilateral in 88 patients and bilateral in 32
At follow-up was recorded whether patients required patients. Six patients had RAS and a single functioning
renal replacement therapy or not (in a binary fashion). kidney. The distribution of the severity of RAS is shown
Also, whenever a renal artery revascularization was per- in Table 1. Patients with incidental RAS were, on aver-
formed during follow-up, it was recorded. The serum cre- age, older than those without RAS, and a slightly smaller
atinine values during follow-up were recorded at two-year number of patients with RAS were male.
intervals. Follow-up data were retrieved by searching
medical records and the electronic medical information Control group and baseline parameters
system of the hospital. In case of insufficient follow-up The control group consisted of 126 randomly selected
data, the patient’s general practitioner and dialysis cen- patients without RAS who were matched for age and
ters were contacted to find out whether these patients sex. Patients with RAS differed from controls on two
needed dialysis. baseline parameters: Significantly more patients with
RAS had a history of coronary artery disease (P 5 0.001).Statistical analysis
Also, patients with RAS had a significantly lower Cock-Comparisons between groups on baseline variables
roft clearance (P 5 0.014; Table 2).were done using Student t tests or chi-squared tests
where appropriate. In addition, differences in serum cre- Follow-up
atinine values during follow-up between the two groups
It proved that none of the 126 patients with RASwere tested using Wilcoxon signed-rank tests. Within the
had ever required renal replacement therapy duringpatient group with RAS, we made a subgroup analysis
follow-up. One control patient without RAS developedto compare patients with unilateral and bilateral RAS.
end-stage renal failure necessitating hemodialysis. Five
patients with RAS underwent revascularization of the
RESULTS renal artery during follow-up, only one of them to treat
renal functional impairment. Serum creatinine valuesDuring the inclusion period, angiograms were made in
during follow-up remained stable in the patients with593 consecutive patients with ischemic peripheral artery
disease (Fig. 1). The renal arteries could be assessed RAS and without RAS (Table 3). No differences with
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Fig. 1. Overview of the study population.
Table 3. Long-term serum creatinine values in patients with RASTable 2. Baseline parameters of the study population
and controls
RAS $50% Controls
N RAS $50% N Controls
N 126 126
Age years 68.869.8 68.369.5 Baseline 126 11263.7 124 9762.7
Follow-upMales % 66 66
History of CAD % 52a 31 0–2 years FU 114 12166.9 113 10465.6
2–4 years FU 62 10264.8 63 9566.1History of CVA % 20 15
Diabetes mellitus % 22 21 4–6 years FU 41 10668.4 47 9667.3
6–8 years FU 25 8764.8 30 8466.3Ever smoked % 73 79
Obesity % 32 40 Values are mean 6 SEM mmol/L.
Cockroft clearance mL/min 58.2622.3a 65.4623.7
Abbreviations are: N, number of patients; CAD, coronary artery disease;
CVA, cerebrovascular accident. Means 6 standard deviation are indicated.
a Statistically significant different from the control group, P , 0.05
ent study confirmed the high prevalence of incidental
RAS of $50% stenosis in patients with peripheral vascu-
lar disease: 33% of 386 patients compared with 31 and
38% in two earlier series of 100 and 189 patients, respec-regard to renal function were found between patients
tively [11, 12]. RAS seems more commonly associatedwith unilateral and bilateral RAS.
with peripheral artery disease than with coronary artery
disease: The prevalence of incidental RAS was reported
DISCUSSION to be only 15% in 1235 patients undergoing cardiac cath-
The clinical importance of incidentally found RAS is eterization [3].
at present uncertain. We aimed to address whether the In our study, incidental RAS was not associated with
disease leads to end-stage renal failure and thus preven- the practical consequences of end-stage renal failure.
None of the 126 patients with untreated incidental RAStive intervention is indicated. As a first finding, the pres-
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